Workflow
吸收合并
icon
Search documents
潜江永安药业股份有限公司第七届董事会第十二次临时会议决议公告
Group 1 - The company approved the absorption merger of its wholly-owned subsidiary, Hubei Ling'an Technology Co., Ltd., which will be dissolved after the merger, with all assets, debts, and rights transferred to the company [1][28]. - The board meeting held on January 6, 2026, had all seven directors participating and unanimously approved the merger proposal [1][28]. - The merger aims to optimize management structure, improve operational efficiency, and reduce management costs [28][33]. Group 2 - The company approved a daily related transaction with Hubei Tian'an Daily Chemical Co., Ltd., with a total transaction amount not exceeding RMB 40 million for the year 2026 [3][16]. - The board meeting saw two related directors abstaining from voting, with five votes in favor and none against [3][16]. - The independent directors had previously reviewed and approved the related transaction proposal before it was presented to the board [4][24]. Group 3 - The company also approved a framework agreement with Hubei Yongbang Engineering Technology Co., Ltd. for equipment processing and manufacturing, with a total amount not exceeding RMB 20 million for 2026 [4][37]. - Similar to the previous transaction, two related directors abstained from voting, and the proposal was approved with five votes in favor [4][37]. - The independent directors confirmed that the transaction is necessary for the company's production needs and does not harm the interests of shareholders [56]. Group 4 - The company scheduled its first extraordinary shareholders' meeting for January 22, 2026, to discuss the approved proposals [14][60]. - The meeting will allow shareholders to vote both in person and via online platforms, ensuring compliance with relevant regulations [60][70]. - The company will provide a detailed voting process for shareholders participating through the internet [70].
易成新能(300080.SZ):拟吸收合并全资子公司恒锐新
Ge Long Hui A P P· 2025-12-31 09:17
Core Viewpoint - The company plans to absorb its wholly-owned subsidiary, Kaifeng Hengrui New Diamond Products Co., Ltd., to improve operational efficiency and reduce management costs [1] Group 1 - The absorption merger aims to further optimize resource allocation within the company [1] - Following the completion of the merger, Hengrui New will be legally dissolved, and all its business, assets, debts, and claims will be inherited by the company [1]
易成新能:拟吸收合并全资子公司恒锐新以优化配置
Xin Lang Cai Jing· 2025-12-31 09:17
Core Viewpoint - The company plans to merge its wholly-owned subsidiary, Hengrui New, to optimize management structure and improve efficiency without affecting financial status or shareholder interests [1] Group 1: Merger Details - The board of directors approved the merger on December 30, 2025, and Hengrui New will be legally dissolved post-merger [1] - The merger does not involve related party transactions or significant asset restructuring, nor does it change the company's registered capital [1] - The merger is pending approval from the shareholders' meeting [1] Group 2: Financial Performance - For the period from January to September 2025, the merging entity reported revenue of 3.01 billion yuan and a net loss of 336 million yuan [1] - The subsidiary being merged reported no revenue and a net loss of 415,300 yuan during the same period [1] Group 3: Strategic Intent - The merger aims to streamline operations and reduce costs while maintaining the company's financial health and protecting shareholder interests [1]
常山药业:12月30日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-12-30 08:24
Group 1 - The company Changshan Pharmaceutical held its sixth board meeting on December 30, 2025, to discuss the proposal for the absorption and merger of its wholly-owned subsidiary [1] - The meeting was conducted in a hybrid format, combining in-person attendance and remote voting [1] Group 2 - A new type of chip has been developed in China, which aims to bypass the restrictions imposed by lithography machines [1] - This new chip supports AI training and embodied intelligence and can be mass-produced using mature processes of 28 nanometers and above [1]
宁波富邦:完成吸收合并全资子公司
Ge Long Hui· 2025-12-19 07:45
Core Viewpoint - Ningbo Fubang (600768.SH) has completed the absorption and merger of its wholly-owned subsidiary, a trading company, which will optimize the company's organizational structure, reduce management costs, and improve operational efficiency [1] Group 1: Merger Details - The company has received a registration notice from the Market Supervision Administration of Jiangbei District, Ningbo, confirming the completion of the merger procedures [1] - The trading company has completed its deregistration, and all assets, debts, and rights and obligations will be legally inherited by the company [1] Group 2: Financial Impact - The merger will not have a substantial impact on the company's financial status, as the trading company's financial statements were already included in the company's consolidated financial reports [1] - The merger is expected to align with the company's development strategy and will not affect its future business development or ongoing profitability [1] Group 3: Strategic Alignment - The absorption and merger are in the best interests of the company and all shareholders, supporting the company's long-term strategic goals [1]
中邮科技(688648.SH):广东信源拟吸收合并信源智能
Ge Long Hui A P P· 2025-12-12 11:39
Core Viewpoint - China Post Technology (688648.SH) announced that its wholly-owned subsidiary, Guangdong Xinyuan Logistics Equipment Co., Ltd. ("Guangdong Xinyuan"), plans to absorb and merge its wholly-owned subsidiary, Xinyuan Intelligent Equipment (Guangzhou) Co., Ltd. ("Xinyuan Intelligent"). This merger is aligned with the company's overall strategy and aims to enhance management efficiency and business synergy, without adversely affecting normal operations or harming the interests of the company and its shareholders [1]. Group 1 - The merger will result in the legal status of Xinyuan Intelligent being canceled, with all assets, liabilities, rights, and operations being inherited by Guangdong Xinyuan [1]. - The absorption and merger are expected to improve management efficiency and business collaboration within the company [1]. - The company asserts that the merger will not negatively impact its normal business operations or shareholder interests [1].
嘉化能源:拟吸收合并子公司
Ge Long Hui· 2025-12-12 08:30
格隆汇12月12日丨嘉化能源(600273.SH)公布,为进一步优化公司管理架构,减少股权层级,提高经营 管理效率、资源有效共享,公司拟吸收合并全资子公司浙江嘉化双氧水有限公司(简称"双氧水")。本 次吸收合并完成后,双氧水独立法人资格将被注销,双氧水拥有或享受的所有资产、债权、人员、利益 以及所承担的责任、债务全部由公司承继,公司将作为经营主体对吸收的资产和业务进行管理。 ...
嘉化能源(600273.SH):拟吸收合并子公司
Ge Long Hui A P P· 2025-12-12 08:18
格隆汇12月12日丨嘉化能源(600273.SH)公布,为进一步优化公司管理架构,减少股权层级,提高经营 管理效率、资源有效共享,公司拟吸收合并全资子公司浙江嘉化双氧水有限公司(简称"双氧水")。本 次吸收合并完成后,双氧水独立法人资格将被注销,双氧水拥有或享受的所有资产、债权、人员、利益 以及所承担的责任、债务全部由公司承继,公司将作为经营主体对吸收的资产和业务进行管理。 ...
新凤鸣集团股份有限公司关于注销2022年回购股份剩余部分暨通知债权人公告
登录新浪财经APP 搜索【信披】查看更多考评等级 股票代码:603225股票简称:新凤鸣 公告编号:2025-117 转债代码:113623转债简称:凤21转债 新凤鸣集团股份有限公司关于注销2022年 回购股份剩余部分暨通知债权人公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担个别及连带责任。 一、通知债权人的原由 新凤鸣集团股份有限公司(以下简称"公司")分别于2025年11月18日、2025年12月4日召开了第六届董 事会第四十二次会议、2025年第七次临时股东会,审议通过了《关于变更公司回购专户2022年回购股份 用途并注销暨减少注册资本的议案》《关于变更公司注册资本暨修订〈公司章程〉的议案》,具体内容 详见公司分别于2025年11月19日、2025年12月5日在上海证券交易所网站(www.sse.com.cn)及公司指 定信息披露媒体《上海证券报》《证券时报》上披露的《新凤鸣集团股份有限公司第六届董事会第四十 二次会议决议公告》(公告编号:2025-113)、《新凤鸣集团股份有限公司2025年第七次临时股东会决 议公告》( ...
泰嘉股份:完成吸收合并全资子公司湖南泽嘉
Xin Lang Cai Jing· 2025-11-21 08:07
Core Viewpoint - The company has completed the absorption merger of its wholly-owned subsidiary, Hunan Zejia, which is expected to enhance resource integration, optimize structure, and improve efficiency without significantly impacting its production, operation, or financial status [1] Group 1 - The merger was officially completed on July 14 and July 31, 2025, with all relevant business registration procedures finalized [1] - Hunan Zejia's legal entity status has been canceled, and all its assets, debts, and claims have been legally inherited by the company [1] - The absorption merger is positioned as beneficial for the company, ensuring no harm to the interests of the company and its shareholders [1]